Latent Labs Secures $50M to Revolutionize Computational Biology

Dr. Simon Kohl's company, Latent Labs, has raised $50 million, with a $40 million Series A round led by Radical Ventures and Sofinnova Partners. The AI-driven biotechnology firm aims to leverage generative AI technologies for the computational generation of new molecules for therapeutic, industrial, and environmental applications.